Ticker
SAGECompany Name
SAGE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -301.19M | -427.77% | $ 70.41M |
3/31/2025 | $ -354.4M | -747.61% | $ 47.4M |
12/31/2024 | $ -400.67M | -971.48% | $ 41.24M |
9/30/2024 | $ -337.59M | -317.29% | $ 106.4M |
6/30/2024 | $ -445.67M | -458.3% | $ 97.24M |
3/31/2024 | $ -503.14M | -552.52% | $ 91.06M |
12/31/2023 | $ -541.49M | -626.32% | $ 86.45M |
9/30/2023 | $ -655.93M | -5779.62% | $ 11.35M |
6/30/2023 | $ -591.62M | -5704.03% | $ 10.37M |
3/31/2023 | $ -557.56M | -5932.09% | $ 9.4M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for SAGE THERAPEUTICS INC is calculated as follows: EBIT [ $ -537.48M ] / Revenues [ $ 6.97M ]
(=) EBIT % [ -7706.84% ]
Minimum
Jun 30, 2022
Maximum
Jun 30, 2021
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.54% |
median | 9.01% |
std | 23.96% |